ZenNews› Health› Wegovy Pill Form Puts U.S. Oral GLP-1 Market on N… Health Wegovy Pill Form Puts U.S. Oral GLP-1 Market on Notice Novo Nordisk's tablet formulation sharpens competition ahead of FDA review cycle. By Oliver Walsh Jun 12, 2026 1 min read Share Share X Facebook WhatsApp Copy link How do you feel about this? 🔥 0 😲 0 🤔 0 👍 0 😢 0 Health Wegovy Pill Form Puts O Oliver Walsh Health & Climate Oliver Walsh analyses medical research, US health policy and climate science. You might also like › Health Pancreatic Cancer Pill Reshapes U.S. Oncology Spending Debate 08 Jun 2026 Health NHS Waiting Lists Top 7.5 Million as GP Crisis Deepens 30 May 2026 Society Youth Mental Health Crisis Strains US Services 18 May 2026 Health How to Get Medical Cannabis in the UK: The Complete Process 19 May 2026 Health Senate Pushes FDA to Expand Prostate Screening Guidelines 30 May 2026 Health AI-Designed Vaccine Reaches U.S. Clinical Pipeline 07 Jun 2026 Also interesting › Economy Trump's Inflation Remark Jolts Fed's Rate-Cut Calculus 9 hrs ago Tech EU's WhatsApp Mandate Puts U.S. AI Firms in Regulatory Crossfire 13 hrs ago Sports Mahomes' $500M Deal Rewrites NFL's Labor Power Map 18 hrs ago Tech Claude's Uncapped Release Puts Liability Question to D.C. 22 hrs ago More in Health › Health Ozempic Muscle Loss Fuels U.S. Drug Pipeline Race 09 Jun 2026 Health Pancreatic Cancer Pill Reshapes U.S. Oncology Spending Debate 08 Jun 2026 Health AI-Designed Vaccine Reaches U.S. Clinical Pipeline 07 Jun 2026 Health Senate Pushes FDA to Expand Prostate Screening Guidelines 30 May 2026 ← Health Ozempic Muscle Loss Fuels U.S. Drug Pipeline Race
